STMN1 and nasopharyngeal carcinoma: The combination of paclitaxel treatment and silencing of stathmin 1 enhanced the tumoricidal effect compared with that of paclitaxel alone, and paclitaxel suppressed the expression of stathmin 1 in nasopharyngeal carcinoma.34